Remove Cardiomyopathy Remove Heart Failure Remove Transplant
article thumbnail

Case report of belt electrode-skeletal muscle electrical stimulation for acute heart failure with severe obesity: a novel therapeutic option for acute phase rehabilitation

Frontiers in Cardiovascular Medicine

However, information on its efficacy and safety in patients with heart failure remains limited. Case presentation A 43-year-old man with a body mass index of 41 kg/m 2 was admitted to our hospital for acute heart failure due to dilated cardiomyopathy. No adverse events were observed during B-SES.

article thumbnail

Black Families at Increased Risk of Inherited Heart Condition That Can Cause Heart Failure at a Young Age

DAIC

Researchers Elizabeth Jordan and Ray Hershberger, MD discuss the results of genetic tests that indicate a risk for dilated cardiomyopathy. The inherited heart condition often goes undiagnosed until it advances to heart failure, which is why it’s important to identify those at risk and begin treatment early.

article thumbnail

Arrhythmias in children undergoing orthotopic heart transplantation

Frontiers in Cardiovascular Medicine

Introduction Heart transplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases. Results We identified 27 children (66.7% On a median follow-up of 35.07 months (IQR: 13.13–111.87),

article thumbnail

PO-01-180 DIFFERENTIAL MIRNA EXPRESSION IN TACHYCARDIA-INDUCED CARDIOMYOPATHY

HeartRhythm

Tachycardia-induced cardiomyopathy (TIC) is a unique cardiomyopathy, which is potentially reversible. Due to the presence of tachyarrhythmias in various cardiomyopathies, differentiating TIC from other non-reversible conditions can be challenging.

article thumbnail

Phenotypes in Arrhythmogenic Cardiomyopathy

All About Cardiovascular System and Disorders

Arrhythmogenic Cardiomyopathy was better known as Arrhythmogenic Right Ventricular Dysplasia or ARVD and sometimes as Arrhythmogenic Right Ventricular Cardiomyopathy or ARVC earlier. A study published in JACC has compared the phenotypic expression and clinical outcomes in patients with arrhythmogenic cardiomyopathy [2].

article thumbnail

Waitlist Outcomes in Candidates With Rare Causes of Heart Failure After Implementation of the 2018 French Heart Allocation Scheme

Circulation: Heart Failure

Circulation: Heart Failure, Ahead of Print. BACKGROUND:In 2018, an algorithm-based allocation system for heart transplantation (HT) was implemented in France. The cumulative incidence of waitlist mortality estimated with competing risk analysis and incidence of transplantation were compared between diagnosis groups.

article thumbnail

Smidt Heart Institute Experts Selected to Join JACC Editorial Team

DAIC

Kittleson, director of Heart Failure Research and director of Post Graduate Medical Education in Heart Failure and Transplantation, is an associate editor specializing in heart failure. She also has served on the board of directors of the Heart Failure Society of America.